Second, to further dismiss the confounding effect of ALK1 at sites of neoangiogenesis, the administration of the ALK1 ligand trap in tumor-free hosts exposes the importance of this signaling pathway in the BM. The gene discussed is ACVRL1; the disease is neoplasm.